The document discusses the importance of the Canadian Top 10 Watch List of New and Emerging Health Technologies (CNESH List) for industry. It notes that the CNESH List provides health authorities with guidance on where to invest based on unmet health needs and innovation. It also suggests that the CNESH List fits into business planning by reinforcing aims to create value for unmet needs and provides the perspective of users and investors. Finally, it proposes ways to enhance the profile of the CNESH List, such as formally collaborating with industry associations.

1. The Canadian Top 10 Watch List of
New and Emerging Health
Technologies
Alain Boisvert, M.Sc (Pharm.)
Vice-President, Market Access & Public Affairs
April 13, 2015

2. Why is the CNESH List Important for Industry?
2
 Health Authorities rely on HTA to guide investment decisions.
 Health Authorities must invest where there are high unmet health needs.
 Innovation and Value.
 Choices must be made for all health technologies, not just drugs.
 Programs (CDR, pCODR, PCPA) are more advanced in drug therapy, but
decisions must span all health technologies.
 CNESH provides this broad perspective to both decision makers and
manufacturers.

3. Where does a Top-10 HT List Fit in Business Planning?
3
 HT discovery and development aimed at creating value for unmet needs.
 A top-10 List reinforces these aims.
 A List provides a user/investor perspective.
 Value in a list developed by an independent authority.
 Development processes increasingly influenced by “Payers” perspective.

4. How can we Enhance the CNESH List Profile?
4
 Not very well known, even across industries that are focused on HT
development.
 Need for a strong institutional anchoring (CADTH).
 Need to move from Academia to Public at large.
 Work with key and specialized press.
 Formal collaboration with industry associations.